Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$1.22B |
| 3 |
Progressive
PGR
|
+$1.12B |
| 4 |
Exelon
EXC
|
+$977M |
| 5 |
Pfizer
PFE
|
+$713M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.5B |
| 2 |
Boston Scientific
BSX
|
+$723M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$709M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$590M |
| 5 |
Expedia Group
EXPE
|
+$558M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.74% |
| 2 | Financials | 15.42% |
| 3 | Technology | 14.93% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
901
DELISTED
Surmodics
SRDX
| $27.7M | 0.01% |
667,677
+205,769
| +45% | +$8.66M |
|
902
Old Dominion Freight Line
ODFL
$44.1B
| $27.6M | 0.01% |
436,272
-205,989
| -32% | -$12.6M |
|
|
HOLI
903
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $27.4M | 0.01% |
1,668,276
-86,155
| -5% | -$1.31M |
|
904
Lindblad Expeditions
LIND
$1.94B
| $27.3M | 0.01% |
1,668,855
-1,113,820
| -40% | -$17.8M |
|
905
American Vanguard Corp
AVD
$68.4M
| $27.2M | 0.01% |
1,399,414
+125,941
| +10% | +$1.98M |
|
906
Dr. Reddy's Laboratories
RDY
$9.87B
| $27.2M | 0.01% |
3,346,860
-1,224,005
| -27% | -$9.67M |
|
907
Pebblebrook Hotel Trust
PEB
$2.15B
| $26.9M | 0.01% |
1,002,706
-50,444
| -5% | -$1.33M |
|
|
DNKN
908
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $26.8M | 0.01% |
355,053
-20,805
| -6% | -$1.57M |
|
909
Syndax Pharmaceuticals
SNDX
$1.69B
| $26.7M | 0.01% |
3,043,690
-53,833
| -2% | -$395K |
|
|
WMGI
910
DELISTED
Wright Medical Group Inc
WMGI
| $26.7M | 0.01% |
876,423
-850,631
| -49% | -$22.3M |
|
911
Lam Research
LRCX
$367B
| $26.7M | 0.01% |
912,060
+127,290
| +16% | +$3.38M |
|
912
Park Hotels & Resorts
PK
$3.03B
| $26.5M | 0.01% |
1,024,396
-281,820
| -22% | -$6.73M |
|
913
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $26.3M | 0.01% |
890,139
+25,051
| +3% | +$713K |
|
914
Autohome
ATHM
$2.67B
| $26.2M | 0.01% |
327,803
+136,567
| +71% | +$10.6M |
|
|
CZR
915
DELISTED
Caesars Entertainment Corporation
CZR
| $26.2M | 0.01% |
1,923,536
-494,768
| -20% | -$6.26M |
|
916
Radian Group
RDN
$5.18B
| $26.1M | 0.01% |
1,036,510
-71,214
| -6% | -$1.77M |
|
917
Red Rock Resorts
RRR
$3.77B
| $26.1M | 0.01% |
+1,088,415
| New | +$24.2M |
|
918
CGI
GIB
$15.1B
| $26.1M | 0.01% |
310,843
-354
| -0.1% | -$28.5K |
|
919
Karyopharm Therapeutics
KPTI
$43.5M
| $26M | 0.01% |
90,575
-293,270
| -76% | -$63.6M |
|
920
Jazz Pharmaceuticals
JAZZ
$15.9B
| $25.8M | 0.01% |
172,977
-58,661
| -25% | -$7.98M |
|
|
LEVL
921
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $25.8M | 0.01% |
1,025,758
-29,437
| -3% | -$723K |
|
|
CDK
922
DELISTED
CDK Global, Inc.
CDK
| $25.7M | 0.01% |
470,500
+150,496
| +47% | +$7.73M |
|
923
PAR Technology
PAR
$699M
| $25.7M | 0.01% |
836,322
-87,100
| -9% | -$2.38M |
|
924
Mativ Holdings
MATV
$481M
| $25.7M | 0.01% |
612,154
-3,628
| -0.6% | -$151K |
|
925
Wave Life Sciences
WVE
$1.09B
| $25.7M | 0.01% |
3,205,313
+118,037
| +4% | +$2.89M |
|
Similar funds
Wellington Management Group's Q4 2019 Portfolio in Review
As of Q4 2019, Wellington Management Group held 2,205 positions worth $477B, up 7.6% from $443B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wellington Management Group's Q4 2019 filing shows 192 new, 703 increased, 960 reduced and 204 closed positions. Its largest new stake was Zoom: 2,196,622 shares worth $149M. The largest sale was Bristol-Myers Squibb, an estimated $1.5B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q4 2019 buy was Zoom: 2,196,622 shares worth $149M.
- Wellington Management Group added most to Apple in Q4 2019, an estimated $2.3B increase.
- Wellington Management Group's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $1.5B.
- Wellington Management Group fully exited Genesee & Wyoming Inc. in Q4 2019, selling an estimated $365M.
- Wellington Management Group's ten largest holdings make up 16% of its $477B portfolio in Q4 2019.
- Wellington Management Group opened 192 new positions and closed 204 in Q4 2019.
- Wellington Management Group's portfolio value rose 7.6% quarter-over-quarter to $477B.
Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.